Taken together, these results indicate that the antiproliferative effects of BAZ1B, Dot1L and menin in ER + BC cells are in all cases directly linked to inhibition of estrogen signaling by clearing ERα form the cell. This evidence concerns the gene DOT1L and breast cancer.